The prestigious channel, GenomeWeb, published an article about “Software Vendors Cautiously Optimistic as Illumina Readies BaseSpace App Store for Market” and mentions Omixon. An excerpt from the article:

Omixon, for instance, is developing an HLA genotyping application for identifying disease associations using whole-genome or whole-exome data as well as from targeted sequencing data, Attila Bérces, the company’s CEO, told BioInform.

You can access the full article here (GenomeWeb subscription is needed). We are always happy when our work gets some attention from the international research communities.